Opinion|Videos|February 12, 2025
Importance of Multidisciplinary Team in Managing AEs of EGFR Inhibitors
Key opinion leaders highlight effective multidisciplinary strategies for managing the diverse range of side effects associated with EGFR inhibitors.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What multidisciplinary strategies have you found most effective in managing the diverse range of side effects associated with EGFR inhibitors?
Advertisement
Related to this article
In a 117-patient cohort, 35% waited over 60 days for neoadjuvant chemotherapy, most often because of added workup, second opinions or comorbidities.
Interviews with 15 young women with breast cancer show fertility preservation decisions unfold under time pressure and carry into survivorship.
Lisa Carter-Bawa, PhD, MPH, APRN, explains how nurses can counter lung cancer fatalism by pairing honesty with hope and using teach-back.
Interim AYA-NAV data show most navigation components reached young patients with cancer as designed, though full sessions lagged during treatment.
As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education and atypical infections.
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Amivantamab for Recurrent or Metastatic HNSCC
2
Teaching Communication as a Clinical Skill for Breast Cancer Care
3
For Young Women With Cancer, Fertility Choices Evolve Beyond Diagnosis
4
Outpatient Tarlatamab Feasible in Community Oncology, Real-World Data Show
5